Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute

Boston, Massachusetts 02115

Use our guide to learn which trials are right for you!

We've found
4 trials
at this facility
Melanoma (Skin) Clinical Trial
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/6/2009
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Laboratory-Treated Peripheral Blood Cell Infusion After Donor Stem Cell Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Status: Enrolling, Phase I
Updated: 11/10/2009
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Sarcoma Clinical Trial
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Status: Enrolling, Phase III
Updated: 6/23/2014
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials